Stock SLNCF SILENCE THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Silence Therapeutics plc OTC Markets

Equities

SLNCF

GB00B9GTXM62

Market Closed - OTC Markets
Other stock markets
 17:02:30 26/06/2024 BST 		5-day change 1st Jan Change
6.5 USD -.--% Intraday chart for Silence Therapeutics plc -.--% +333.33%
06-28 European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading MT
06-28 Chardan Raises Price Target on Silence Therapeutics to $55 From $42, Maintains Buy Rating MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Silence Therapeutics plc Announces Retirement of Alistair Gray from Board of Directors, Effective May 1, 2024
CI
Silence Therapeutics plc Announces Executive Changes
CI
Silence Therapeutics plc Announces Retirement of Giles Campion as Chief Medical Officer, Head of Research & Development and Member of Board
CI
Silence Therapeutics plc Appoints Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
CI
Aptamer Names Former Pharnext Finance Chief as CFO
MT
Silence Therapeutics plc Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLN Stock
  4. SLNCF Stock
  5. News Silence Therapeutics plc
  6. Insiders